Key facts
- Notable investors include Lotus Lake Ventures, Beijing Hanhong Investment, China Nuclear Industry Fund Management, XinRay Systems.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for NuRay Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for NuRay Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NuRay Technology
Developer of distributed imaging systems intended for diagnostic, inspection, and screening applications. The company offers carbon nanotube cold cathode multi-beam X-ray technology, enabling high-speed static CT imaging, low-dose multi-angle projection, and real-time 3D reconstruction across medical, dental, industrial, and security domains, serving healthcare providers, manufacturers, and inspection agencies to achieve enhanced imaging precision, reduced radiation exposure, and scalable throughput for complex diagnostic and non-destructive testing workflows.
- Sector
- Healthcare
- HQ
- Changzhou, China
- Founded
- 2015
- Employees
- 102
- Website
- nuraytech.com/
- Ownership
- Privately Held (backing)
NuRay Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NuRay Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NuRay Technology in its N-PORT filings yet. We sweep new filings monthly.